An article with the above title appears in a new issue of The ASCO Post, and is based on a recent presentation by Dr. William Oh (of Mount Sinai School of Medicine, New York) at a “Best of ASCO” educational meeting held in Boston earlier in the year. For those trying to understand how to think about future opportunities for the use of abiraterone acetate, enzalutamide, and radium-223 in advanced and metastatic forms of prostate cancer, this overview may be helpful.
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment Tagged: | abiraterone, castration-resistant, enzalutamide, mCRPC, metastatic, radium-223
Search for new and
ongoing trials on the
CTAG PCa web site
What about hemp? Cannabis appears to be a ready made cure all for cancer. If we all stand together, we can force the issue on the government. It may take long guns and cannon, but it needs to happen. We killed prohibition of alcohol, so the precedent has already been set.
FS
Dear Fred:
I am not aware of any published data whatsoever on the clinical effectiveness and safety of cannabis specific to the management of prostate cancer. While it is possible that cannabis and its active ingredients may be able to ameliorate pain and anxiety in some men with late stages of prostate cancer, the lack of actual data makes it difficult to justify its clinical use — and the idea that it is some sort of “ready made cure all” is simply not justifiable at all.
The link is, unfortunately, not working.
Jean
Sorry Jean. Technical glitch. It should be working now.
Mike,
Interesting. Very recently I was told by two different New York-based oncologists that they believed I could benefit from early use of MDV3100. However, I would most likely need to pay for it out of pocket. I been have told the insurance companies will reject payment but I may be able win on appeal and that a least one of the hospitals has had some sucess in winning the apeals.
Bill
Bill:
I would also think there was a decent chance that you could have a good response to enzalutamide. However, that is a lot of money to have to pay out of your own pocket. Why not try for preapproval? The insurance companies all know that early use of this drug is just a matter of time. In your favor is the fact that you have already had docetaxel-based chemotherapy.
Thanks Mike, and yes … sounds like a good way to go.
Best,
Bill